BidaskClub cut shares of HealthEquity, Inc. (NASDAQ:HQY) from a buy rating to a hold rating in a report published on Monday, July 24th.
Other equities analysts have also issued reports about the stock. Oppenheimer Holdings, Inc. reaffirmed an outperform rating and issued a $61.00 price target (up from $57.00) on shares of HealthEquity in a report on Monday, June 12th. Zacks Investment Research raised shares of HealthEquity from a hold rating to a buy rating and set a $54.00 price target on the stock in a report on Wednesday, July 12th. Cantor Fitzgerald boosted their price objective on shares of HealthEquity from $55.00 to $56.00 and gave the company an overweight rating in a report on Wednesday, July 5th. Finally, Chardan Capital boosted their price objective on shares of HealthEquity from $53.00 to $57.00 and gave the company a buy rating in a report on Wednesday, June 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $50.22.
Shares of HealthEquity (NASDAQ HQY) opened at 42.08 on Monday. The company has a 50 day moving average price of $47.91 and a 200 day moving average price of $46.04. The stock has a market cap of $2.52 billion, a P/E ratio of 79.10 and a beta of 1.73. HealthEquity has a 1-year low of $28.39 and a 1-year high of $54.95.
HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Tuesday, June 6th. The company reported $0.19 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.16 by $0.03. The company had revenue of $55.40 million for the quarter, compared to analyst estimates of $54.77 million. HealthEquity had a net margin of 17.04% and a return on equity of 11.61%. HealthEquity’s revenue was up 25.9% compared to the same quarter last year. During the same period last year, the company posted $0.15 earnings per share. On average, equities analysts anticipate that HealthEquity will post $0.58 EPS for the current year.
WARNING: This news story was originally published by BNB Daily and is owned by of BNB Daily. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.baseball-news-blog.com/2017/08/19/healthequity-inc-nasdaqhqy-cut-to-hold-at-bidaskclub-updated-updated-updated.html.
In other news, major shareholder Berkley Capital, Llc sold 248,351 shares of the business’s stock in a transaction dated Tuesday, June 13th. The shares were sold at an average price of $52.80, for a total transaction of $13,112,932.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Frank Medici sold 210,906 shares of the business’s stock in a transaction dated Wednesday, June 14th. The stock was sold at an average price of $52.03, for a total transaction of $10,973,439.18. Following the sale, the director now directly owns 6,381 shares of the company’s stock, valued at approximately $332,003.43. The disclosure for this sale can be found here. In the last quarter, insiders sold 2,449,321 shares of company stock valued at $125,721,793. Insiders own 29.00% of the company’s stock.
Hedge funds have recently added to or reduced their stakes in the company. Alps Advisors Inc. boosted its stake in HealthEquity by 0.3% in the second quarter. Alps Advisors Inc. now owns 10,729 shares of the company’s stock worth $535,000 after buying an additional 28 shares in the last quarter. Neuburgh Advisers LLC boosted its stake in HealthEquity by 0.4% in the first quarter. Neuburgh Advisers LLC now owns 31,968 shares of the company’s stock worth $1,357,000 after buying an additional 112 shares in the last quarter. Albion Financial Group UT boosted its stake in HealthEquity by 1.4% in the second quarter. Albion Financial Group UT now owns 8,694 shares of the company’s stock worth $433,000 after buying an additional 120 shares in the last quarter. Glen Harbor Capital Management LLC boosted its stake in HealthEquity by 0.4% in the first quarter. Glen Harbor Capital Management LLC now owns 43,956 shares of the company’s stock worth $1,866,000 after buying an additional 154 shares in the last quarter. Finally, Oppenheimer Asset Management Inc. boosted its stake in HealthEquity by 7.7% in the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after buying an additional 191 shares in the last quarter. 90.54% of the stock is owned by institutional investors and hedge funds.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.